Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Stephan Baldus Added: 1 year ago
TCT Conference 2024 - Clinical outcomes between percutaneous mitral valve repair (PMVR) and mitral valve surgery in patients with atrial mitral regurgitation (MR).Dr Stephan Baldus (University of Köln Medical Center, DE) joins us onsite at TCT Conference to discuss the findings from MATTERHORN (NCT02371512; University of Köln).MATTERHORN is a multicenter, randomized controlled clinical trial,… View more
Author(s): Volker Rudolph , Stephan Baldus Added: 1 year ago
ESC Congress 2024 — TEER non-inferior to mitral valve surgery with regard to death, HF rehospitalisation, stroke, reintervention of LVAD at one year.Dr Volker Rudolph (Heart and Diabetes Center NRW, DE) and Prof Stephan Baldus (University Hospital of Köln, DE) joins us in London to discuss the MATTERHORN trial (NCT02371512; University Hospital of Köln).This multicenter, randomized controlled… View more
Author(s): Added: 1 month ago
Learn more about how to evaluate imaging in patients with mitral valve (MV) disease who are potential candidates for mitral transcatheter edge-to-edge repair (M-TEER) with Prof Marta Sitges (University of Barcelona, Barcelona, ES).This two-part video lecture series, part of the Structural Interventions track of Women As One's CLIMB® 2025 Skills Training Program, provides essential insights into… View more
Author(s): Rania Hammami , Uthman Aluthman Added: 6 months ago
TCT Middle East 2025 — We are joined by Prof Rania Hammami and Dr Uthman Aluthman as they discuss the key takeaways for minimally invasive surgery from the conference.The specialists provide insights on evolving definitions and expanding applications of minimally invasive cardiac surgical techniques. They address practical considerations regarding patient selection, recovery trajectories, and… View more
Author(s): , Start date: Aug 06, 2025
Mitral and tricuspid regurgitation remain under-recognised and undertreated despite their significant impact on symptoms, quality of life, and outcomes. In this expert-led webinar, Suzanne V. Arnold, MD (Saint Luke’s Health System, Kansas City, US) offers practical guidance on recognising heart valve disease early, navigating referral pathways, and integrating patient-centred data into everyday… View more
Added: 2 months ago Source:  Transcatheter Academy
For patients with symptomatic left-sided mechanical prosthetic valve thrombosis (PVT), the optimal treatment strategy between urgent surgery and fibrinolytic therapy (FT) has been uncertain. The SAFE-PVT trial, the first randomised controlled trial (RCT) to directly compare these approaches, found that while surgery is associated with a higher risk of complications and death, FT often results in… View more